天津泰达资源循环集团股份有限公司 累积投票制度 （2014 年 10 月 30 日 2014 年第六次临时股东大会审议通过，2025 年 11 月 27 日 2025 年第六次临时股东会修订） 第一章 总则 第一条 为在公司董事选举过程中，充分反映中小股东的意见，依法保障其 合法权益，根据《公司法》《上市公司章程指引》《深圳证券交易所上市公司自 律监管指引第 1 号——主板上市公司规范运作》等有关法律、法规、规章、规范 性文件及公司章程等有关规定，制定本制度。 第二条 公司单一股东及其一致行动人拥有权益的股份比例在 30%及以上 时，公司选举 2 名及以上董事应当采用累积投票制。 第三条 股东会选举 2 名以上独立董事或 2 名以上非独立董事时，应当实行 累积投票制。公司补选或更换 1 名董事时，仍然采用一股一票的投票方法，不采 用累积投票制。 第四条 本制度所称累积投票制，是指公司股东会在选举 2 名以上的董事时， 股东所持的每一股份拥有与当选董事总人数相等的投票权，股东既可以用所有的 投票权集中投票选举一人，也可以分散投票选举数人，按得票多少依次决定董事 人选的表决权制度。 第五条 本制度所称"董事"包括 ...

公司重大信息报告制度是指当出现、发生或即将发生可能对公司股票及其衍生品 种的交易价格产生较大影响的情形或事件时，按照本制度规定负有报告义务的有关人 员、部门、各子公司，应第一时间将有关信息向董事会秘书和证券部进行报告的制度。 第三条 本制度适用于公司、全资子公司、控股子公司及实际控制企业（以下称 "各子公司"）。 天津泰达资源循环集团股份有限公司 重大信息报告制度 （2021 年 4 月 13 日第九届董事会第五十八会议审议通过，2025 年 11 月 11 日第十一届董事会第二十五次（临时）会议修订） 第一章 总则 第一条 为规范天津泰达资源循环集团股份有限公司（以下简称"公司"）重大 信息报告工作，保证公司内部重大信息得到有效传递和审核控制，并及时、真实、准 确、完整地披露信息，维护投资者的合法权益，根据《中华人民共和国公司法》《中 华人民共和国证券法》《上市公司信息披露管理办法》《深圳证券交易所股票上市规 则》（以下简称"《股票上市规则》"）《深圳证券交易所上市公司自律监管指引第 1 号-——主板上市公司规范运作》（以下简称"《规范运作指引》"）等有关法律、法 规、规范性文件和《天津泰达资源循环集团股份 ...

天津泰达资源循环集团股份有限公司 第二条 独立董事是指不在公司担任除董事外的其他职务（独立董事不得在 公司兼任除董事会专门委员会委员外的其他职务），并与其所受聘的公司及其主 要股东、实际控制人不存在直接或间接利害关系，或者其他可能影响其进行独立 客观判断关系的董事。 第三条 公司董事会成员应当有三分之一以上的独立董事，其中至少有一名 会计专业人士。 第四条 独立董事专门会议是指由全部公司独立董事参加的会议。 第二章 职责与权限 第五条 下列事项应当经公司独立董事专门会议讨论并经全体独立董事过半 数同意后方可提交董事会审议： （一）应当披露的关联交易； 独立董事专门会议工作细则 （2023 年 12 月 13 日第十届董事会第四十一次（临时）会议审议通过，2025 年 11 月 11 日第十一届董事会第二十五次（临时）会议修订） 第一章 总 则 第一条 为进一步完善天津泰达资源循环集团股份有限公司（以下简称"公 司"）的法人治理，充分发挥独立董事在公司治理中的作用，根据《中华人民共 和国公司法》《中华人民共和国证券法》《上市公司独立董事管理办法》《深圳 证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指 ...

天津泰达资源循环集团股份有限公司 证券投资管理制度 （2007 年 5 月 26 日 2006 年度股东大会审议通过，2009 年 5 月 25 日 2008 年 度股东大会第一次修订；2013 年 6 月 5 日第七届董事会第二十七次（临时）会 议第二次修订；2025 年 11 月 27 日 2025 年第六次临时股东会第三次修订） 第一章 总则 第一条 为规范天津泰达资源循环集团股份有限公司（以下简称"公司"） 证券市场投资行为，加强对短期投资的管理，进一步明确投资流程及审批程序， 保护投资者利益；根据《中华人民共和国公司法》《中华人民共和国证券法》《深 圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第7号—— 交易与关联交易》等有关法律、法规和规范性文件的规定，结合《天津泰达资源 循环集团股份有限公司章程》，特制定本制度。 第二条 本制度所称证券市场投资包含：新股申购、国债回购，及在控制投 资风险的前提下，以提高资金使用效率和收益最大化为原则，在证券市场投资有 价证券的行为。 第三条 证券市场投资应遵循确保资金安全、效益优先、量力而行的原则。 第四条 公司相关部门在进行证券市场投资前，应 ...

天津泰达资源循环集团股份有限公司 未来三年（2025-2027 年）股东回报规划 （2025 年 11 月 27 日 2025 年第六次临时股东会审议通过） 为完善和健全天津泰达资源循环集团股份有限公司（以下简称"公司"）科 学、持续、稳定的分红决策和监督机制，积极回报投资者，引导投资者树立长期 和理性投资的理念，提升全体股东的长期回报，公司根据《中华人民共和国公司 法》（以下简称"《公司法》"）、中国证券监督管理委员会《上市公司监管指 引第 3 号——上市公司现金分红》和《公司章程》等有关规定，结合公司实际情 况，制定了《未来三年（2025-2027 年）股东回报规划》（以下简称"本规划"）， 具体内容如下： 一、本规划的制定原则 二、本规划制定的考虑因素 公司股东回报规划着眼于公司的长远和可持续发展，在综合考虑公司战略发 展目标、股东意愿的基础上，结合公司盈利情况和现金流量状况、经营发展规划 及企业所处的发展阶段、资金需求情况、社会资金成本以及外部融资环境等因素， 依据《公司章程》规定，建立对投资者持续、稳定、科学的分红回报规划与机制， 并对利润分配做出制度性安排，以保证利润分配政策的连续性和稳定性。 三 ...

证券代码：000652 证券简称：泰达股份 公告编号：2025-110 天津泰达资源循环集团股份有限公司 关于续聘 2025 年度会计师事务所的公告 （一）机构信息 本次拟续聘会计师事务所中审亚太会计师事务所（特殊普通合伙）（以下简 称"中审亚太"）符合财政部、国务院国资委、证监会印发的《国有企业、上市 公司选聘会计师事务所管理办法》（财会〔2023〕4 号）的规定。 天津泰达资源循环集团股份有限公司（以下简称"公司"）于 2025 年 11 月 11 日召开第十一届董事会第二十五次（临时）会议审议通过了《关于续聘 2025 年度会计师事务所的议案》，公司通过公开招投标拟续聘中审亚太为公司 2025 年度审计会计师事务所，聘期一年，上述事项尚需提交公司股东会审议。具体情 况如下： 1. 基本信息 （2）成立日期：2013 年 1 月 18 日 （3）组织形式：特殊普通合伙 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 一、拟续聘会计师事务所的基本情况 特别提示： （1）会计师事务所名称：中审亚太会计师事务所（特殊普通合伙） （4）注册地址：北京市海淀区复兴路 ...

Market Overview - On November 7, the comprehensive sector rose by 1.24% compared to the previous trading day, with Sanmu Group leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - Sanmu Group (000632) closed at 4.94, up 10.02% with a trading volume of 1.1862 million shares and a turnover of 569 million [1] - Zhangzhou Development (000753) closed at 10.02, up 9.99% with a trading volume of 1.3087 million shares and a turnover of 1.229 billion [1] - Other notable performers include Yuegui Co. (000833) up 3.50%, and Te Li A (000025) up 1.50% [1] Capital Flow - The comprehensive sector saw a net inflow of 411 million in main funds, while retail funds experienced a net outflow of 274 million [2] - The main funds showed significant inflows into Zhangzhou Development (2.6 billion) and Sanmu Group (127 million) [3] Individual Stock Capital Flow - Sanmu Group had a main fund net inflow of 127 million, accounting for 22.31% of its total [3] - Zhangzhou Development experienced a net outflow of 1.145 billion from retail investors, indicating a negative sentiment among smaller investors [3] - Dongyangguang (600673) had a main fund net inflow of 114 million, while retail investors showed a net outflow of 1.236 billion [3]

Core Insights - The chelating agent industry is experiencing innovation and upgrades due to technological advancements, with a focus on developing new, environmentally friendly products such as green and natural chelating agents, which are gaining market acceptance [1][7] - The market size for China's chelating agent industry is projected to reach approximately 11.772 billion yuan in 2024, reflecting a year-on-year growth of 5.29% [1][8] Industry Overview - Chelating agents are compounds that can form stable ring structures with metal ions, preventing precipitation, corrosion, or participation in chemical reactions. They can be categorized into inorganic and organic types, with most being organic compounds [2][4] Chelating Agent Classification - Inorganic chelating agents, such as sodium tripolyphosphate, have strong chelation capabilities but pose environmental risks, leading to bans in the EU. In contrast, organic chelating agents like EDTA and DTPA have high stability constants for heavy metals but have low biodegradability [4][5] Industry Chain - The upstream of the chelating agent industry includes raw materials like ethylenediamine and citric acid, while the midstream involves the production of chelating agents. The downstream applications span water treatment, metal processing, textiles, daily chemicals, agriculture, and pharmaceuticals [5][6] Market Size - The chelating agent market in China is expected to grow to approximately 11.772 billion yuan in 2024, with a year-on-year increase of 5.29% [1][8] Key Companies' Performance - The industry is characterized by a multi-polar competitive landscape, with leading companies like Shijiazhuang Jack Chemical dominating the market. Smaller firms focus on niche segments, such as Shaoxing Xingxin New Materials, which has achieved a 99% raw material conversion rate in heavy metal capture [9][10] Industry Development Trends 1. Environmental policies are accelerating the demand for biodegradable chelating agents, with products like GLDA and MGDA gaining traction as alternatives to traditional EDTA [10][11] 2. Technological innovations, including bio-fermentation and nanotechnology, are driving the development of high-end products, enhancing production efficiency and reducing chemical consumption [11][12] 3. Industry consolidation and globalization are being pursued by leading companies to lower costs and enhance international competitiveness, with local firms expanding into Southeast Asian markets [12]

Group 1 - Jinguang Electric won a bid for a State Grid procurement project with a total amount of 21.7976 million yuan, accounting for approximately 2.93% of the company's expected revenue for 2024 [1] - Shen Gong Co. plans to reduce its shareholding by up to 2%, equating to 340.61 million shares [2] - Guomai Culture received a government subsidy of 3.78 million yuan, representing 24.90% of its audited net profit for 2024 [2] Group 2 - Guomai Culture focuses on the development and provision of digital content operation platforms [3] - Shentong Technology's two directors plan to collectively reduce their shareholding by no more than 0.0473% [4] - Ruihua Tai intends to reduce its shareholding by up to 1%, amounting to 1.8 million shares [5] Group 3 - Guoji Automobile's wholly-owned subsidiary won a total contract project worth 809 million yuan [7] - Changcheng Technology's stock is expected to remain suspended due to potential changes in control [9] - Huabei Pharmaceutical's subsidiary received approval for a chemical raw material drug listing application [11] Group 4 - Fuyao Glass has changed its legal representative to Cao Hui [13] - Huaxi Biological plans to reduce its shareholding by up to 2%, totaling 9.6336 million shares [14] - Hopu Co. signed a procurement contract for a storage system worth 500 million yuan [15] Group 5 - ST Songfa's subsidiary plans to invest 458 million yuan in a mooring dock project [18] - Zhonghong Medical's subsidiary is expected to be selected for several centralized procurement projects [19] - Huakai Yibai's vice chairman plans to increase his shareholding by no less than 30 million yuan [20] Group 6 - Haichuang Pharmaceutical completed the first participant enrollment for a clinical trial of a drug for metabolic-associated fatty liver disease [21] - Dongfang Biological's subsidiary obtained medical device product registration certificates for multiple products [22] - Lepu Medical's rechargeable implantable deep brain stimulation system received NMPA registration approval [23] Group 7 - Changyuan Power's power generation in October decreased by 32.25% year-on-year [24] - Jinshi Yaya's diclofenac sodium sustained-release tablets passed the consistency evaluation for generic drugs [26] - Yutong Bus sold 3,040 buses in October, a decrease of 5.62% year-on-year [27] Group 8 - Far East Co. signed contracts worth 1.062 billion yuan in October [28] - Tianya Pharmaceutical's subsidiary passed the consistency evaluation for a drug [29] - Yuheng Pharmaceutical plans to resolve a debt dispute through a share transfer agreement [30] Group 9 - Hailanxin's subsidiary won a bid for a marine observation network project worth 1.097 billion yuan [31] - Huasheng Lithium plans to reduce its shareholding by up to 0.37% [33] - Maike Biological obtained product registration certificates for five new in vitro diagnostic products [34] Group 10 - Huayuan New Materials signed a strategic cooperation agreement with Taiblue New Energy [37] - Greebo's actual controller and some directors plan to collectively increase their shareholding by no less than 11.5 million yuan [39] - Yian Technology received a government subsidy of 1.1643 million yuan [41] Group 11 - Kangtai Biological's quadrivalent influenza virus vaccine has commenced Phase I clinical trials [43] - Spring Airlines received a commitment letter for a stock repurchase loan of up to 450 million yuan [45] - Foton Motor sold 8,006 new energy vehicles in October, a year-on-year increase of 98.83% [46] Group 12 - Greebo plans to transfer 100% equity of its subsidiary for 280 million yuan [48] - Siwei Liekong's director is under investigation [49] - Dingyang Technology launched a new generation of multi-channel microwave signal generator products [50] Group 13 - Jiangling Motors reported a year-on-year increase of 8.06% in vehicle sales for October [51] - Shengyi Technology plans to reduce its shareholding by up to 1.03% [52] - Dongshan Precision completed the acquisition of 100% equity of France's GMD Group for approximately 814 million yuan [53] Group 14 - Tianyang Technology plans to acquire 7.5% of Baoland's shares for 155 million yuan [54] - Alter plans to establish a joint venture company with a total investment of 672 million yuan [54] - Changchun High-tech's clinical trial application for a drug was approved [55] Group 15 - Beibu Gulf Port's cargo throughput in October increased by 22.73% year-on-year [56] - ST Zhangjiajie was ruled by the court to undergo reorganization [57] - Teda Co.'s subsidiary was selected as a supplier for an energy project in Indonesia [58]

Core Viewpoint - The company, Tianjin TEDA Co., Ltd. (stock code: 000652), announced a share buyback plan, having repurchased a total of 6,394,989 shares, which represents 0.433% of its current total share capital as of October 31, 2025 [1] Summary by Category - **Share Buyback Details** - The company has utilized a dedicated securities account for the share buyback, executing the repurchase through centralized bidding [1] - The total number of shares repurchased is 6,394,989 [1] - This repurchase accounts for 0.433% of the company's total share capital [1]